Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methods for documenting antiarrhythmic efficacy.

D C Harrison

    The American Journal of Cardiology
    |September 22, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Documenting antiarrhythmic drug efficacy is challenging due to patient variability. A statistical model using linear regression offers a promising, quantifiable method for assessing drug effectiveness in treating arrhythmias.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Quasiparticle Poisoning of Superconducting Qubits from Resonant Absorption of Pair-Breaking Photons.

    Physical review letters·2024
    Same author

    The ratios of iron to oxygen, iron to colour and oxygen to colour in the blood of men and women.

    The Journal of physiology·2010
    Same author

    Fiber optics oximeter-densitometer for cardiovascular studies.

    Applied optics·2010
    Same author

    Specific cardiac indications for routine lidocaine use.

    Anesthesia progress·2009
    Same author

    The distribution of the orphan bombesin receptor subtype-3 in the rat CNS.

    Neuroscience·2003
    Same author

    Increased cortical expression of the orexin-1 receptor following permanent middle cerebral artery occlusion in the rat.

    Neuroscience letters·2002
    Same journal

    Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

    The American journal of cardiology·2026
    Same journal

    ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

    The American journal of cardiology·2026
    Same journal

    Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

    The American journal of cardiology·2026
    Same journal

    Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

    The American journal of cardiology·2026
    Same journal

    Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

    The American journal of cardiology·2026
    Same journal

    Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

    The American journal of cardiology·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology
    • Biostatistics

    Background:

    • Assessing antiarrhythmic drug efficacy is complex due to significant patient variability in arrhythmia presentation and response.
    • Current methods for quantifying treatment success, such as symptom reduction or ambulatory monitoring, have limitations in precision, cost, or time.

    Purpose of the Study:

    • To evaluate the effectiveness of a statistical model based on linear regression for quantifying antiarrhythmic drug efficacy.
    • To address the limitations of existing methods in documenting treatment outcomes for antiarrhythmic medications.

    Main Methods:

    • Utilized a statistical model employing linear regression analysis with established 95% and 99% confidence intervals.
    • Compared the efficacy of quinidine and encainide using this novel statistical approach.

    Related Experiment Videos

    Main Results:

    • The statistical model successfully demonstrated efficacy in comparing quinidine and encainide.
    • This approach provides a quantifiable measure of antiarrhythmic drug effectiveness, overcoming limitations of previous methods.

    Conclusions:

    • A statistical model utilizing linear regression analysis offers a robust and quantifiable method for documenting antiarrhythmic drug efficacy.
    • Wider application of this statistical model is recommended for future studies evaluating antiarrhythmic treatments.